Information about the 2019 Novel Coronavirus
ExAblate Transcranial MRgFUS Thalamotomy Treatment
Trial ID or NCT#
The objective of this prospective, randomized, double-blind (to subjects, local site's blinded assessor and Tremor Core Lab assessors), crossover, multi-site, two-arm study (ExAblate treated arm Vs ExAblate Sham treated control arm) is to test the efficacy of treatment using the ExAblate Transcranial System and to further demonstrate safety in medication-refractory tremor in subjects with essential tremor (ET).
Contact us to find out if this trial is right for you.
About this Clinical Trial
Your Message Will Go ToJennifer Marcellus
Go Back To The Trial